Vorinostat Completed Phase 1 Trials for Relapsing Chronic Myelogenous Leukemia / Recurrent Childhood Small Noncleaved Cell Lymphoma / Childhood Burkitt Lymphoma / Recurrent Childhood Medulloblastoma / Childhood Immunoblastic Large Cell Lymphoma / Recurrent Childhood Acute Myeloid Leukemia / Recurrent/Refractory Childhood Hodgkin Lymphoma / Unspecified Childhood Solid Tumor, Protocol Specific / Childhood Atypical Teratoid/Rhabdoid Tumor / Recurrent Neuroblastoma / Childhood Chronic Myelogenous Leukemia / Recurrent Childhood Acute Lymphoblastic Leukemia / Juvenile Myelomonocytic Leukemia / Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor / Recurrent Childhood Grade III Lymphomatoid Granulomatosis / Childhood Diffuse Large Cell Lymphoma / Recurrent Childhood Large Cell Lymphoma / Recurrent Childhood Lymphoblastic Lymphoma / Childhood Acute Promyelocytic Leukemia (M3) Treatment